Zuclopenthixol Ong-Acting Im Injection (Depot) 200 mg/mL, 500 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Long-acting IM Injection (Depot)
Available Strengths: 200 mg/mL, 500 mg/mL
Reference Brands: Clopixol Depot®(US)
Category: Antipsychotropic Drugs
Zuclopenthixol is a typical antipsychotic that works by blocking dopamine (D2) receptors in the brain, reducing psychotic symptoms. It’s primarily used as a long-acting intramuscular injection to manage schizophrenia, particularly in patients with poor medication compliance. It helps maintain symptom control over extended periods.
Product Description: Zuclopenthixol long-acting IM injection, a typical antipsychotic depot formulation, is not FDA-approved in the United States but is widely authorized in the EU under the brand Clopixol Depot. In Europe, it follows EMA guidelines for long-acting injectable neuroleptics, indicated for schizophrenia and related psychoses. EU compliance requires GMP manufacturing, stability data, and pharmacovigilance alignment. U.S. market entry may involve a 505(b)(2) pathway and complete ANDA dossier. To explore dossier-ready forms, formulations, and global suppliers of Zuclopenthixol long-acting IM injection, visit Pharmatradz.com.
Zuclopenthixol Ong-Acting Im Injection (Depot) — third party manufacturing & bulk supply
Zuclopenthixol Ong-Acting Im Injection (Depot) 200 mg/mL, 500 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Zuclopenthixol Ong-Acting Im Injection (Depot) is supplied as Long-acting IM Injection (Depot) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Zuclopenthixol Ong-Acting Im Injection (Depot) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Zuclopenthixol Ong-Acting Im Injection (... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Lithium Carbonate
Strength:
150 mg, 300 mg, 600 mg
Form: Tablets
Reference Brands: Lithobid (USA/LATAM), Priadel (EU)
View Details
Phenobarbital Sodium
Strength:
65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
